← Tools
Medical Benefit
PAMS Access Toolkit
Billing codes unverified

Ilumya — buy and bill, or refer out?

Office-administered and infused products bill under the medical benefit, not the pharmacy benefit. Different form, different queue, different codes — and the first decision is whether the office can carry the drug at all.

Is the office set up for buy and bill?

Carrying the drug means buying it, stocking it and billing it. Most dermatology offices are not set up for it, and the referral path is the normal answer — but it has its own failure mode, which is that a referred start stalls invisibly.

Billing identifiers

1 product populated
10-digit NDC
47335-177-95
Ordering from the distributor
11-digit NDC
47335-0177-95
Claim submission — the padded format payers expect
HCPCS J-code
J3245
How the drug is billed on the medical claim
HCPCS descriptor and billing unit
Injection, tildrakizumab-asmn, 1 mg
Units billed must match the descriptor's unit, not the vial
Place of service
Physician office
Plans restrict where the drug may be given
Administration CPT
not in our data — must be sourced
Injection or infusion administration is billed separately from the drug
Verify before you billConfirmed against the binder's own medical-benefit block: 10-digit NDC for ordering 47335-177-95, 11-digit for claim submission 47335-0177-95, HCPCS J3245, descriptor 'Injection, tildrakizumab-asmn, 1 mg', site of service physician office. The administration CPT is still not stated anywhere and is still not to be guessed. Verify every field against the CMS quarterly file before billing.
Answer the question above and the workflow appears here.

Usage events this tool reports

0 events
No events yet.